BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25732549)

  • 1. The advancement of human serum albumin-based molecular probes for molecular imaging.
    Cao W; Lu X; Cheng Z
    Curr Pharm Des; 2015; 21(14):1908-15. PubMed ID: 25732549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human serum albumin conjugated biomolecules for cancer molecular imaging.
    Yang M; Hoppmann S; Chen L; Cheng Z
    Curr Pharm Des; 2012; 18(8):1023-31. PubMed ID: 22272822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the Influence of Different Albumin Binders on Molecular Imaging Probe Distribution.
    Höltke C; Grewer M; Stölting M; Geyer C; Wildgruber M; Helfen A
    Mol Pharm; 2021 Jul; 18(7):2574-2585. PubMed ID: 34048242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing the bioavailability of small molecular optical imaging probes by conjugation to an albumin affinity tag.
    Hahnenkamp A; Alsibai W; Bremer C; Höltke C
    J Control Release; 2014 Jul; 186():32-40. PubMed ID: 24815420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromatographic analysis of the effects of fatty acids and glycation on binding by probes for Sudlow sites I and II to human serum albumin.
    Anguizola J; Debolt E; Suresh D; Hage DS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 May; 1021():175-181. PubMed ID: 26468085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycolaldehyde and maleyl conjugated human serum albumin as potential macrophage-targeting carriers for molecular imaging purposes.
    Gustafsson B; Hedin U; Caidahl K
    Contrast Media Mol Imaging; 2015; 10(1):37-42. PubMed ID: 24753457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of interactions between platinum-/ruthenium-based anticancer agents and human serum albumin: development of HSA carrier for metal-based drugs.
    Gou Y; Zhang Y; Yang F; Liang H
    Curr Pharm Des; 2015; 21(14):1848-61. PubMed ID: 25732554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of subdomain IIA binding site of human serum albumin in its native, unfolded, and refolded states using small molecular probes.
    Abou-Zied OK; Al-Shihi OI
    J Am Chem Soc; 2008 Aug; 130(32):10793-801. PubMed ID: 18642807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smart human serum albumin-indocyanine green nanoparticles generated by programmed assembly for dual-modal imaging-guided cancer synergistic phototherapy.
    Sheng Z; Hu D; Zheng M; Zhao P; Liu H; Gao D; Gong P; Gao G; Zhang P; Ma Y; Cai L
    ACS Nano; 2014 Dec; 8(12):12310-22. PubMed ID: 25454579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of the fusion protein RGD-HSA-TIMP2 as a tumor targeting imaging probe for SPECT and PET.
    Choi N; Kim SM; Hong KS; Cho G; Cho JH; Lee C; Ryu EK
    Biomaterials; 2011 Oct; 32(29):7151-8. PubMed ID: 21719102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybrid lymph node imaging using 64Cu-labeled mannose-conjugated human serum albumin with and without indocyanine green.
    Kang CM; An GI; Choe YS
    Nucl Med Commun; 2015 Oct; 36(10):1026-34. PubMed ID: 26068310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Red-Emitting Conjugated Polyelectrolyte: Stabilization by Interaction with Biomolecules and Potential Use as Drug Carriers and Bioimaging Probes.
    Kahveci Z; Vázquez-Guilló R; Martínez-Tomé MJ; Mallavia R; Mateo CR
    ACS Appl Mater Interfaces; 2016 Jan; 8(3):1958-69. PubMed ID: 26709951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on drug-human serum albumin binding: the current state of the matter.
    Zhivkova ZD
    Curr Pharm Des; 2015; 21(14):1817-30. PubMed ID: 25732557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide-based fibrin-targeting probes for thrombus imaging.
    Oliveira BL; Caravan P
    Dalton Trans; 2017 Oct; 46(42):14488-14508. PubMed ID: 29051933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-invasive optical imaging of matrix metalloproteinase activity with albumin-based fluorogenic nanoprobes during angiogenesis in a mouse hindlimb ischemia model.
    Ryu JH; Shin JY; Kim SA; Kang SW; Kim H; Kang S; Choi K; Kwon IC; Kim BS; Kim K
    Biomaterials; 2013 Sep; 34(28):6871-81. PubMed ID: 23773822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of anticancer drug clofarabine with human serum albumin and human α-1 acid glycoprotein. Spectroscopic and molecular docking approach.
    Ajmal MR; Nusrat S; Alam P; Zaidi N; Khan MV; Zaman M; Shahein YE; Mahmoud MH; Badr G; Khan RH
    J Pharm Biomed Anal; 2017 Feb; 135():106-115. PubMed ID: 28012306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging Tumor Metastases with Molecular Probes.
    Qiao R; Zhu R; Gao M
    Curr Pharm Des; 2015; 21(42):6260-4. PubMed ID: 26503140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodistribution and excretion of monosaccharide-albumin conjugates measured with in vivo near-infrared fluorescence imaging.
    McCann TE; Kosaka N; Mitsunaga M; Choyke PL; Gildersleeve JC; Kobayashi H
    Bioconjug Chem; 2010 Oct; 21(10):1925-32. PubMed ID: 20853850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-Induced Self-Assembly of Modified Albumins as Nano-theranostics for Tumor-Targeted Combination Therapy.
    Chen Q; Wang X; Wang C; Feng L; Li Y; Liu Z
    ACS Nano; 2015 May; 9(5):5223-33. PubMed ID: 25950506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular imaging and targeted drug delivery using albumin-based nanoparticles.
    Yhee JY; Lee J; Chang H; Lee J; Kwon IC; Kim K
    Curr Pharm Des; 2015; 21(14):1889-98. PubMed ID: 25732551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.